Literature DB >> 33712084

Deciphering the functional role of EGR1 in Prostaglandin F2 alpha induced luteal regression applying CRISPR in corpus luteum of buffalo.

Meeti Punetha1, Sai Kumar2, Avishek Paul2, Bosco Jose2, Jaya Bharati3, Arvind Sonwane4, Jonathan A Green5, Kristin Whitworth5, Mihir Sarkar2.   

Abstract

BACKGROUND: PGF2α is essential for the induction of the corpus luteum regression which in turn reduces progesterone production. Early growth response (EGR) proteins are Cys2-His2-type zinc-finger transcription factor that are strongly linked to cellular proliferation, survival and apoptosis. Rapid elevation of EGR1 was observed after luteolytic dose of PGF2α. EGR1 is involved in the transactivation of many genes, including TGFβ1, which plays an important role during luteal regression.
METHODS: The current study was conducted in buffalo luteal cells with the aim to better understand the role of EGR1 in transactivation of TGFβ1 during PGF2α induced luteal regression. Luteal cells from mid stage corpus luteum of buffalo were cultured and treated with different doses of PGF2α for different time durations. Relative expression of mRNAs encoding for enzymes within the progesterone biosynthetic pathway (3βHSD, CYP11A1 and StAR); Caspase 3; AKT were analyzed to confirm the occurrence of luteolytic event. To determine if EGR1 is involved in the PGF2α induced luteal regression via induction of TGFβ1 expression, we knocked out the EGR1 gene by using CRISPR/Cas9. RESULT: The present experiment determined whether EGR1 protein expression in luteal cells was responsive to PGF2α treatment. Quantification of EGR1 and TGFβ1 mRNA showed significant up regulation in luteal cells of buffalo at 12 h post PGF2α induction. In order to validate the role of PGF2α on stimulating the expression of TGFβ1 by an EGR1 dependent mechanism we knocked out EGR1. The EGR1 ablated luteal cells were stimulated with PGF2α and it was observed that EGR1 KO did not modulate the PGF2α induced expression of TGFβ1. In PGF2α treated EGR1 KO luteal cell, the mRNA expression of Caspase 3 was significantly increased compared to PGF2α treated wild type luteal cells maintained for 12 h. We also studied the influence of EGR1 on steroidogenesis. The EGR1 KO luteal cells with PGF2α treatment showed no substantial difference either in the progesterone concentration or in StAR mRNA expression with PGF2α-treated wild type luteal cells.
CONCLUSION: These results suggest that EGR1 signaling is not the only factor which plays a role in the regulation of PGF2α induced TGFβ1 signaling for luteolysis.

Entities:  

Keywords:  Buffalo; CRISPR/Cas9; Corpus luteum; EGR; Luteolysis

Mesh:

Substances:

Year:  2021        PMID: 33712084      PMCID: PMC7953609          DOI: 10.1186/s40659-021-00333-7

Source DB:  PubMed          Journal:  Biol Res        ISSN: 0716-9760            Impact factor:   5.612


  50 in total

1.  Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection.

Authors:  Xiquan Liang; Jason Potter; Shantanu Kumar; Yanfei Zou; Rene Quintanilla; Mahalakshmi Sridharan; Jason Carte; Wen Chen; Natasha Roark; Sridhar Ranganathan; Namritha Ravinder; Jonathan D Chesnut
Journal:  J Biotechnol       Date:  2015-05-21       Impact factor: 3.307

2.  Patterns of gene expression in the bovine corpus luteum following repeated intrauterine infusions of low doses of prostaglandin F2alpha.

Authors:  Mehmet O Atli; Robb W Bender; Vatsal Mehta; Michele R Bastos; Wenxiang Luo; Chad M Vezina; Milo C Wiltbank
Journal:  Biol Reprod       Date:  2012-04-27       Impact factor: 4.285

3.  A calcium/calmodulin-dependent activation of ERK1/2 mediates JunD phosphorylation and induction of nur77 and 20alpha-hsd genes by prostaglandin F2alpha in ovarian cells.

Authors:  Carlos O Stocco; Lester F Lau; Geula Gibori
Journal:  J Biol Chem       Date:  2001-11-21       Impact factor: 5.157

4.  Stimulation of intracellular free Ca2+ by luteinizing hormone in isolated bovine luteal cells.

Authors:  J S Davis
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

5.  Prostaglandin F2alpha regulates distinct physiological changes in early and mid-cycle bovine corpora lutea.

Authors:  S J Tsai; M C Wiltbank
Journal:  Biol Reprod       Date:  1998-02       Impact factor: 4.285

6.  Activation of the second promoter of the transforming growth factor-beta 1 gene by transforming growth factor-beta 1 and phorbol ester occurs through the same target sequences.

Authors:  S J Kim; F Denhez; K Y Kim; J T Holt; M B Sporn; A B Roberts
Journal:  J Biol Chem       Date:  1989-11-15       Impact factor: 5.157

7.  Early transcriptome responses of the bovine midcycle corpus luteum to prostaglandin F2α includes cytokine signaling.

Authors:  Heather Talbott; Xiaoying Hou; Fang Qiu; Pan Zhang; Chittibabu Guda; Fang Yu; Robert A Cushman; Jennifer R Wood; Cheng Wang; Andrea S Cupp; John S Davis
Journal:  Mol Cell Endocrinol       Date:  2017-05-23       Impact factor: 4.102

8.  Effect of prostaglandin F2 alpha on local luteotropic and angiogenic factors during induced functional luteolysis in the bovine corpus luteum.

Authors:  Bajram Berisha; Heinrich H D Meyer; Dieter Schams
Journal:  Biol Reprod       Date:  2010-01-07       Impact factor: 4.285

9.  Prostaglandin F2alpha stimulates the expression and secretion of transforming growth factor B1 via induction of the early growth response 1 gene (EGR1) in the bovine corpus luteum.

Authors:  Xiaoying Hou; Edward W Arvisais; Chao Jiang; Dong-bao Chen; Shyamal K Roy; Joy L Pate; Thomas R Hansen; Bo R Rueda; John S Davis
Journal:  Mol Endocrinol       Date:  2007-10-04

10.  The zinc-finger transcription factor, early growth response 3, mediates VEGF-induced angiogenesis.

Authors:  D Liu; I Evans; G Britton; I Zachary
Journal:  Oncogene       Date:  2007-12-03       Impact factor: 9.867

View more
  1 in total

1.  Spatiotemporal expression pattern of miR-205, miR-26a-5p, miR-17-5p, let-7b-5p, and their target genes during different stages of corpus luteum in Egyptian buffaloes.

Authors:  Sally Ibrahim; Mohamed O Taqi; A S A Sosa; Al-Shimaa Al-H H El-Naby; Karima Gh M Mahmoud; Hassan R H Darwish; Amal R Abd El Hameed; M F Nawito
Journal:  J Genet Eng Biotechnol       Date:  2022-02-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.